Print Version
2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar
Author:
Global Tuberculosis Institute at Rutgers The State University of New Jersey, Curry International TB Center, Heartland National Tuberculosis Center, Southeastern National Tuberculosis Center, Mayo Clinic Center for Tuberculosis, Curry International TB Center, SNTC
Publication Date:
2016
Format:
Webinar
Language:
English
How to Access this Material:
HTML: http://www.currytbcenter.ucsf.edu/trainings/2016-atscdcidsa-clinical-practice-guidelines-treatment-drug-susceptible-tuberculosis
HTML: http://www.currytbcenter.ucsf.edu/trainings/2016-atscdcidsa-clinical-practice-guidelines-treatment-drug-susceptible-tuberculosis
Abstract
The 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis webinar provides an overview of the guidelines development process, key changes in recommendations, and the evidence supporting the changes.Publisher:
Global Tuberculosis Institute at Rutgers The State University of New Jersey
Audience(s):
Health Professionals
Topic:
Treatment- TB Disease
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.